You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Secondary Metabolites of Sarraceniaceae Family: Comparison
View Latest Version
Please note this is a comparison between Version 3 by Jason Zhu and Version 2 by Jason Zhu.

Carnivorous plants have fascinated researchers and hobbyists for centuries because of their mode of nutrition which is unlike that of other plants. They are able to produce bioactive compounds used to attract, capture and digest prey but also as a defense mechanism against microorganisms and free radicals. Darlingtonia, Heliamphora and Sarracenia plants are rich in compounds with potential pharmaceutical and medical uses. These belong to several classes such as flavonoids, with flavonol glycosides being the most abundant, monoterpenes, triterpenes, sesquiterpenes, fatty acids, alkaloids and others. Some of them are well characterized in terms of chemical properties and biological activity and have widespread commercial applications. Sarraceniaceae species contain numerous substances with the potential to advance health. 

  • Sarraceniaceae
  • secondary metabolites
  • biological activity

1. Flavonoids

Flavonoids belong to a class of plant-derived secondary metabolites with low molecular weight and a variable polyphenolic structure. They have the C6–C3–C6 general structural backbone in which the two C6 units (Ring A and Ring B) are of phenolic nature. Due to the hydroxylation pattern and variations in the chromane ring (Ring C), flavonoids can be further divided into different sub-groups such as anthocyanins, chalcones, flavanones, flavones, flavonols, isoflavonoids and flavan-3-ols (flavanols). The basic structures of flavonoids are aglycones but in plants most of them exist as glycosides. Their biological activities are dependent on both the structural difference and the glycosylation patterns [491][2]50]. Flavonoids are responsible for the color of fruits and flowers. Throughout the evolution of terrestrial plants, flavonoids have helped them gain frost hardiness and drought resistance and acted as UV filters and antimicrobial defense compounds [51,52][3][4]. Flavonoids are naturally found in fruits, vegetables, grains and certain beverages such as tea, cocoa and wine [53][5]. They are added to foods and food supplements but have also become an indispensable component of nutraceutical, pharmaceutical, medicinal and cosmetic applications [50][2]. The great interest in flavonoids stems from their anti-inflammatory, antimicrobial, antioxidant and antitumor properties [54,55][6][7]. Flavonoids are distributed in all Sarracenia leaf parts with the highest content being found in the operculum, the topmost part of the leaf, where they create variegation which lures insects and protect plant cells from light-produced free radicals [37,56][8][9].

1.1. Anthocyanidins

Anthocyanins are a subgroup of flavonoids that have the C6-C3-C6 flavan or 2-phenylbenzodihydorpyrane skeleton [57][10]. More than 700 anthocyanins have been identified in nature [58][11]. In plants, they provide various colors such as red, pink, blue and purple and play key roles in plant reproduction by attracting pollinators and seed dispersers. Anthocyanins also help protect plants against abiotic and biotic stresses such as pathogens and predators, ultraviolet radiation, reactive oxygen species (ROS) and climate conditions [59,60][12][13]. Anthocyanins can be divided based on their substitutions, especially at Ring B, or the glycosylation at Rings A and C of the skeleton. The main sugars are the monosaccharides glucose, arabinose, galactose or the disaccharide rutinose (6-O-α-L-rhamnosyl-D-glucose) [57,61][10][14]. The color and stability, both chemical and physiological, of these pigments are influenced by pH, light, temperature and structure such as glycosylation and acylation patterns [62,63][15][16]. Anthocyanins without a sugar attached are called anthocyanidins. Cyanidin and delphinidin are the two most common anthocyanidins found in plant tissues with proportions of 50% and 12%, respectively [64][17].
High concentrations of anthocyanins are present in the operculum and upper leaf part of several Sarracenia hybrids [37][8]. Cyanidin is the main anthocyanidin detected in leaves of S. flava, S. leucophylla, S. psittacina, S. purpurea and S. rubra and in flowers of S. rubra and S. leucophylla [34][18]. Blue pigments detected in Sarracenia flowers were later identified as delphinidin glycosides [65][19].
A large quantity of delphinidin is present in S. purpurea petals (44%) and a smaller one (11%) in S. psittacina flowers [34][18]. Identification of minor anthocyanidins and of the sugars attached to the major ones requires further study.

Biological Activity

Anthocyanins in general and cyanidin and delphinidin in particular exhibit a broad range of pharmacological activities such as antioxidant [66][20], anticancer [67][21], antiobesity [68][22], cardioprotective, neuroprotective [57,69][10][23] and antidiabetic [63][16]. That is why several patents have been granted for research related to delphinidin use in cosmetics, anticancer therapy or as an antimicrobial agent [70][24]. Cyanidin and its glycosides display neuroprotective effects both in cells cultured in vitro [71][25] and in rats [72][26]. Cyanidin is part of a recently defined class of cancer chemopreventive agents called antimetastatic agents [73][27]. Delphinidin shows anticancer activity against cells from a variety of cancers such as breast, ovarian, colon, prostate, lung, hepatic, bone, blood and skin. In most cancers, it interferes with protein targets of the phosphatidylinositol 3 kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) and mitogen-activated protein kinase (MAPK) signaling pathways [70][24]. It has also been shown to act against ovarian cancer synergistically with agents such as cisplatin and paclitaxel [74][28]. Both cyanidin and delphinidin have chemopreventive action against skin cancer [75][29]. Delphinidin displays cardioprotective and antihypertensive activity by reducing cardiac hypertrophy, cardiac dysfunction and oxidative stress [76][30]. High doses of anthocyanins have the potential to modulate carbohydrate metabolism and blood glycemic levels, and help reduce cardiovascular risk factors [77][31]. Delphinidin is reported to be a potent inhibitor of osteoclast differentiation and considered an effective agent for preventing bone loss in women with postmenopausal osteoporosis [78][32]. It can also reduce muscle atrophy in mice [79][33] while cyanidin has potential for treating patients with rheumatoid arthritis [80][34]. Delphinidin acts directly on viral particles of the hepatitis C virus and impairs their attachment to the cell surface [81][35]. It was also found to be effective against certain strains of the Zika virus [82][36] and to cure Staphylococcus aureus infection [83][37].

1.2. Flavonols, Flavonol Glycosides and Flavononol Glycosides

Flavonols are a class of flavonoids that have the 3-hydroxyflavone backbone with a double bond at the 2–3 position and a hydroxyl group at the 3 position. Despite being low molecular weight compounds, they present a great variability in terms of structural features [84][38]. In higher plants, flavonols are widely distributed in glycosylated form, with the most abundant being O-glycosides [85,86][39][40].
The major flavonoid components are similar in all Sarracenia species with some variation in the “rubra complex” [87][41]. Although metabolite profiling has recently been carried out for a large number of accessions belonging to several species [9][42], the most studied members of the genus with respect to chemical composition are S. flava [16,18,46,47][43][44][45][46] and S. purpurea. Based on in vitro assays S. purpurea, is considered among the most biologically active species traditionally used by the indigenous Cree of James Bay (Canada) against diabetes [88][47]. Water and ethanol extracts from S. purpurea leaves and roots contain flavonols and flavonol glycosides together with flavan-3-ols [26,39,40][48][49][50]. The most abundant flavonol glycoside is taxifolin-3-O-glucoside with 90.659 mg/g in the ethanol extract and 39.094 mg/g in the water extract, followed by quercetin-3-O-galactoside with 34.833 mg/L and 20.784 mg/L, respectively [40][50]. Quercetin-3-O-galactoside is known to be one of the active principles of Vaccinium vitis-idaea berries [89][51].

1.2.1. Biological Activity of S. purpurea Extracts

S. purpurea ethanol extract is more potent than metformin in increasing glucose uptake in C2C12 mouse muscle cells under basal and insulin-stimulated conditions. Isorhamnetin-3-O-glucoside, kaempferol-3-O-(6″-caffeoylglucoside) and quercetin-3-O-galactoside are believed to be the active principles which potentiate glucose uptake in vitro [26][48].
S. purpurea ethanol extract activates the AMP-activated protein kinase (AMPK) pathway and augments the expression of glucose transporter type 4 (GLUT4). The water extract intensifies glucose uptake by activating the insulin pathway that involves Akt. Quercetin-3-O-galactoside and quercetin 3-O-α-L-arabinopyranoside are biomarkers for the water extract that stimulates glucose uptake [35,90][52][53]. The ethanol plant extract also reduces activity of glucose-6-phosphatase, which is a key enzyme in gluconeogenesis and increases glucose storage by stimulating glycogen synthase activity. These actions result in a reduction in glucose production by rat hepatoma cells [26][48]. The extract also protects PC12 rat neuronal cells from death caused by hyper- or hypoglycemic conditions with the active compounds being quercetin-3-O-galactoside and the irridoid morroniside [41][54]. Therefore, it can be said that S. purpurea extract lowers blood glycaemia and protects against complications of diabetes [26][48]. However, it can potentially be harmful to renal cells such as the MDCK cell line by enhancing the activity of caspases and inducing apoptosis [91][55].
The biological activity of S. purpurea extracts is partly due to the presence of various types of flavonoids. Some are the focus of intense research and their multiple biomedical effects have resulted in the production of drugs and dietary supplements while others are less investigated.

1.2.2. Biological Activity of Taxifolin

Taxifolin (dihydroquercetin) or 5,7,3′,4′-flavan-on-ol is a flavanonol with two stereocenters on the C-ring and methylation of C-3, C-5 and C-7 [92][56]. Its glycosides can be found in medicinal plants such as Hypericum perforatum [93][57]. In in vitro and in vivo studies, taxifolin displays a wide range of health-promoting effects and biological activities such as antioxidant, anti-inflammatory, anti-Alzheimer, anticancer and antiangiogenic.
The structural orientation of taxifolin makes this compound capable of scavenging free radicals which corresponds to its antioxidant efficacy [94][58]. As shown by in vitro bioassays, when compared with standard antioxidant compounds such as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) α-tocopherol or Trolox, taxifolin has marked antioxidant, reducing ability, radical-scavenging and metal-chelating activities. This is why taxifolin can be used for minimizing or preventing lipid oxidation in food or pharmaceutical products which results in maintaining product nutritional quality and prolonging shelf life [95][59]. Taxifolin antioxidant activity is associated with blood capillary protection [96][60] and it is also exhibited through its neuroprotective effects via the inhibition of oxidative neuronal injuries in rat cortical cells [97][61].
Taxifolin can regulate the activation of nuclear factor kappa B (NF-κB) in rats diagnosed with cerebral ischemia–reperfusion injury. Furthermore, it is also associated with the suppression of leukocyte infiltration and inhibits the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in the brain [98][62]. In vitro, it represses osteoclastogenesis through the receptor activator of nuclear factor kappa Β ligand (RANKL). RANKL-induced gene expression is suppressed by taxifolin without significant cytotoxicity, a finding which is supported by bone loss prevention in an in vivo mouse model [99][63]. Taxifolin inhibits degranulation, generation of leukotriene C4 (LTC4), production of interlukin-6 (IL-6) and expression of COX-2 in bone marrow-derived mast cells [100][64]. This means that taxifolin could potentially be used for the treatment of allergic and inflammatory diseases [95][59]. Taxifolin has hepatoprotective effects because it decreases liver lesions, vacuole formation, neutrophil infiltration, necrosis and levels of malondialdehyde (MDA) which is a marker of oxidative stress and increases the activity of antioxidant enzymes [101][65].
Taxifolin has the ability to maintain the normal lipid profile in serum and liver of rats fed a cholesterol-rich diet. Normal lipid excretion in feces is also conserved [102][66]. An in vivo study also shows that taxifolin-treated animals exhibit lower levels of total liver cholesterol [103][67]. The neuroprotective role and anti-Alzheimer activity of taxifolin are justified by the inhibition of enzymes responsible for infection and inflammatory response in the brain stem [95][59].
Taxifolin acts as an antagonist on the epidermal EGFR and PI3K receptor, resulting in several effects, including antiproliferative and chemotherapeutic activity, on various cancer model systems [95,104][59][68]. It also has antiangiogenic activity proven by the in vitro inhibition of new blood vessel and branch formation [105][69].

1.2.3. Biological Activity of Kaempferol and Kaempferol Derivatives

Kaempferol (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a tetrahydroxyflavone that has hydroxy groups located at positions 3, 5, 7 and 40. Kaempferol and its glycosylated derivatives have a variety of activities such as antioxidant, anti-inflammatory, cardioprotective, neuroprotective and anticancer [106,107][70][71]. Kaempferol has a beneficial role in different inflammatory-related illnesses such as cancers and cardiovascular and neurodegenerative diseases. Its actions result from the inhibition of inflammatory cell function and proinflammatory cytokines, chemokines and enzymes cyclooxygenase 1 (COX-1) and COX-2 [108,109][72][73]. The cyclooxygenase pathway is activated when a physical, chemical or mechanical trauma occurs at any site of the body. The arachidonic acid produced after rupture of the phospholipidic membranes is converted into prostaglandin analogues by cyclooxygenase enzymes and causes inflammation. Inhibition of the enzymes prevents this process [110][74]. Besides cyclooxygenase, kaempferol inhibits the expression of lipo-oxygenase (LOX) and iNOS which are also involved in inflammation [108][72]. This is confirmed by studies in rabbits which found that kaempferol is a potential antiatherogenic agent which prevents vascular inflammation [111][75]. In clinical trials, a kaempferol-rich diet significantly reduced proinflammatory cytokines such as interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-α) which are inflammatory biomarkers [112,113][76][77]. A clinical study found that a higher intake of kaempferol is associated with a significantly decreased hazard ratio of advanced prostate cancer [114][78]. Kaempferol has a free radical-scavenging effect and inhibitory effect against lipid peroxidation in vitro [115][79]. Treatment with kaempferol heightens cell viability in response to oxidative stress, which includes unstable radicals prone to harming DNA. Kaempferol activates MAPK which can prevent the DNA damage that leads to the transformation of healthy cells into cancerous ones. Protective effects seem to only apply to normally functioning body cells while administration of kaempferol actually increases oxidative stress in cancerous glioblastoma cells by intensifying ROS production [116][80]. Kaempferol acts against cancer cells through several mechanisms such as inducing DNA damage and inhibiting expression of proteins associated with DNA repair in human promyelocytic leukemia HL-60 cells [117][81]. It also enhances cell cycle arrest in the G2/M phase in MDA-MB-231 breast cancer cells [118][82]. Kaempferol has chemopreventive effects against hepatocellular carcinoma by inducing autophagy, cell cycle arrest and sustained endoplasmic reticulum (ER) stress that leads to cellular damage and eventually triggers apoptosis by activating the mitochondrial intrinsic apoptotic pathway [119][83]. Kaempferol alone exhibits inhibitory time- and dose-dependent effects on liver cancer cell lines with little toxicity to normal hepatocytes. In the same experiment, combining kaempferol with the chemotherapeutic drug doxorubicin resulted in a stronger inhibitive effect on the viability of liver cancer cells and higher suppression of colony formation, cell cycle progression, DNA damage response and mitochondrial function [120][84]. The growing needs of tumors are met by the formation of new blood vessels. Vascular endothelial growth factor (VEGF) is the primary mediator of this process, termed angiogenesis [121][85]. Kaempferol impairs cancer angiogenesis both in vitro and in vivo through the inhibition of VEGF secretion in human cancer cell lines [122][86]. Kaempferol-3-O-rutinoside is an antioxidant that promotes apoptosis in cancer cells [123][87] and also has antifungal action against Candida strains [124][88]. Rutin, kaempferol-3-O-rutinoside and kaempferol-3-O-robinobioside have high anti-HSV-1 activity [125][89].

1.2.4. Biological Activity of Quercetin-3-O-galactoside

Quercetin-3-O-galactoside (hyperoside) is present in plants from the genera Hypericum and Crataegus and is considered a therapeutic agent for the treatment of vascular inflammatory diseases via inhibition of the high-mobility group box 1 protein (HMGB1) signaling pathway [126][90]. It reduces, in a dose-dependent manner, lipopolysaccharide (LPS)-induced proliferation, migration and inflammatory responses by suppressing activation of the NF-κB signaling pathway which results in an anti-inflammatory effect in collagen-induced arthritis [127][91]. Hyperoside displays antifibrotic effects on cultured human hepatic LX-2 cells, which are mediated by the inhibition of NF-κB signaling and the induction of apoptosis in activated hematopoietic stem cells (HSCs). This makes hyperoside a potential candidate in the search for pharmacological agents to combat liver fibrosis [128][92].

1.2.5. Biological Activity of Quercetin-3-O-glucoside

Querpcetin-3-O-glucoside (isoquercetrin) is one of the naturally occurring glucosides of quercetin and a predominant metabolite of quercetin in animal and human plasma [129][93]. Evidence shows that quercetin has great therapeutic potential in the prevention and treatment of different chronic disorders, including cardiovascular and neurodegenerative diseases, as well as cancer [130][94]. Isoquercetrin has potential protective effects against oxidative neuronal injuries and brain ischemia [97][61]. It also increases cerebral blood flow and possess antihypoxic activity [131][95]. Quercetin-3-O-glucoside alleviates oxidative stress, reduces ethanol-induced cytotoxicity and protects hepatic cells against ethanol-induced liver injury [132][96]. It is known to suppress the infiltration of pancreatic cancer cells in a dose-dependent manner. This antimigratory effect is exerted at a relatively low dose compared to other forms of quercetin [133][97]. Isoquercetrin exhibits significant cytotoxic action on human cervical cancer cells (HeLa) in a dose- and time-dependent manner with potent antioxidant as well as anti-inflammatory effects. Proliferation is inhibited via cell cycle arrest and apoptosis through increased generation of ROS, disruption of cellular homeostasis which eventually leads to DNA damage and cell death [134][98]. Quercetin-3-O-glucoside has a more potent antiproliferative effect than quercetin and quercetin-3-O-rutinoside (rutin) [135][99].
Quercetin and its glycosides display significant activity against the Mayaro virus [136][100] and the anti-influenza A virus [137][101]. Quercetin-3-O-glucoside is efficient against Ebola virus, both in vitro and in vivo [138][102], and it inhibits the replication of Zika virus in a dose-dependent manner [139][103]. Streptomyces antibioticus synthetizes a quercetin 3-O-glucoside derivative which is active in vitro, against numerous microorganisms such as: S. aureus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, Fusarium moniliforme, Aspergillus niger and Aspergillus flavus [140][104].

1.2.6. Biological Activity of Quercetin-3-O-rutinoside

Quercetin-3-O-rutinoside (rutin) is a glycoside comprising the flavonol aglycone quercetin along with disaccharide rutinose and characterized by a β-glycosidic bond [141][105]. It possesses a broad spectrum of pharmacological activities that make it a desirable therapeutic agent in various pharmaceutical formulations or cosmeceuticals. Rutin is used for the treatment of chronic venous insufficiency [142][106]. It inhibits the apoptosis of cardiomyocytes and improves cardiac function in a mouse model. This effect is probably related to the restoration of the structure and function of myocardial mitochondria [143][107]. Rutin also reduces high blood pressure, arteriosclerosis risk and the permeability of blood vessels [144][108]. It is employed medicinally to reduce capillary fragility associated with some hemorrhagic diseases or hypertension in humans [145][109]. Due to the ability of rutin to ameliorate various neurodegenerative processes, it has been proposed as a neuroprotective compound for the treatment of Alzheimer’s disease, Parkinson’s disease and Huntington’s disease [146][110].
Rutin is active against UV radiation-induced damage due to its structural similarity to organic UV filters and strong antioxidant activity which can inhibit the UVB-induced inflammatory responses mediated by COX-2 and iNOS. Its ability to improve skin dermal density, reduce fine winkles and enhance elasticity make this flavonol a major ingredient in antiaging cosmetics [147,148][111][112].
The therapeutic potential of rutin is of great interest, especially as far as antiproliferative and antioxidant effects for many diseases are concerned. At micromolar concentrations, rutin possesses a dose-dependent cytotoxic effect against human melanoma cells. This is associated with a reduced viability rate, changes in cellular morphology, apoptotic-like nuclear alterations and reduced confluence [149][113]. Rutin can inhibit and regulate the cell cycle in the G2 and G1 phases. It stimulates apoptosis and downregulates certain oncogenic pathways including the NF-κB pathway and phosphorylation of the p38 MAPK pathway. It also inhibits growth in human glioblastoma cell lines through induction of apoptosis and cell cycle arrest in the G2/M phase, as well as regulation of expression of the pro- and antiapoptotic genes (Bcl-2, Cas-3, Bax and TP53) [150,151][114][115]. Quercetin-3-O-rutinoside increases caspase activity resulting in an apoptotic effect in prostate cancer cells [152][116]. It modulates various signaling pathways such as activators of transcription, MAPK, PI3K/Akt and Wnt/β-catenin signaling cascades and Janus kinase/signal transducers in carcinogenic cells. The Ras/Raf and PI3K/Akt, MAPK and TGF-β2/Smad2/3Akt/PTEN signaling pathways are stimulated through the epidermal growth factor (EGF) signaling pathway [153,154][117][118]. Rutin has been demonstrated to directly bind to the epidermal growth factor receptor (EGFR) protein and arrest the downstream signaling factors [155][119].
Rutin is effective in other species, not just humans. It inhibits the expression of various apoptotic markers, which may improve the health status of the mammary glands of sheep. Supplementation with rutin increases fat mobilization to provide energy and alleviate metabolic stress during the 3 weeks before calving and the 3 weeks after calving [156][120]. Another interesting element is the ability of rutin and its derivative rutin succinate to inhibit metalloproteinases from the venom of the Brazilian pit viper Bothrops jararaca, protecting mice from venom toxicity and ensuring their survival. These findings indicate that rutin has potential as complementary treatment for snakebites [157,158][121][122].
The antiviral activity of kaempferol, quercetin and their derivatives is well demonstrated which has resulted in several studies that investigate flavononol activity against SARS-CoV-2. These have found that administration of quercetin to COVID-19 outpatients significantly reduces the need for or the length of hospitalization, noninvasive oxygen therapy, progression to intensive care units, decreases time until virus clearance and deaths without peculiar side effects [159,160][123][124]. Rutin has the potential to induce strong inhibition against SARS-CoV-2 spike protein and main protease, resulting in a reduction in viral load [161][125].

2.3. Biological Activity of Flavan-3-ols

S. purpurea extracts contain two flavan-3-ols: (+)-catechin and (−)-epicatechin. Both are antioxidants and their activity is exerted through direct mechanisms such as scavenging of ROS and chelating metal ions but also through indirect mechanisms such as induction of antioxidant enzymes, inhibition of pro-oxidant enzymes and production of phase II detoxification enzymes and antioxidant enzymes [162][126]. Catechins may act as therapeutic agents to inhibit oxidative damage and inflammation by suppressing oxidative stress-related pathways responsible for inflammation processes through the reduction in interleukin 5 (IL-5) and interleukin 13 (IL-13) levels [163,164,165][127][128][129]. Catechins inhibit oxidative damage and inflammation through the crosstalk between the MAPK and NF-κB pathways [166][130]. In cardiac mitochondria, epicatechin uncoupled oxidation from phosphorylation, at low concentrations stimulated phosphorylation, inhibited the respiratory chain at higher concentrations and released cytochrome c from mitochondria. These data suggest that the beneficial effects of epicatechin and its derivatives might be due to direct modulation of mitochondrial functions [167][131]. Catechin protects bone marrow-derived mesenchymal stem cells from oxidative stress-induced apoptosis [168][132]. It also influences the molecular mechanisms involved in angiogenesis, extracellular matrix degradation, regulation of cell death and multidrug resistance in cancer and related disorders [169][133]. As catechin showed in vitro inhibition of amyloid fibril formation [170][134], the two flavan-3-ols were tested in vivo either separately or in combination and reduced amyloid plaques in mouse or rat models [171][135]. The presence of amyloid fibrils as plaques is a key feature of several neurodegenerative diseases, in particular Alzheimer’s. This disease is characterized by amyloid aggregates formed from amyloid beta (Aβ) peptide that are deposited inside the brain or are toxic to neuronal cells [172][136]. Catechins and other biophenols are proposed as weapons against Alzheimer’s disease and other neurodegenerative disorders [173,174][137][138].

2. Monoterpenes

Most of the monoterpenes identified to date in Sarraceniaceae plants belong to the class called iridoids which have a cyclopentane pyran structure [175][139]. Among these compounds, sarracenin was first discovered in root extract of S. flava [43][140], in the nectaries of two Heliamphora species [17][141], in another four species, S. alata, S. leucophylla, S. purpurea and S. rubra [44][142], and more recently in three additional ones, S. psittacina, S. purpurea and D. californica [9][42].

Biological Activity

Sarracenin shows significant antimicrobial activities against S. aureus, Streptococcus pyogenes, Shigella dysenteriae, Klebsiella pneumonia, Candida albicans, Candida tropicalis, Candida thrusei and Candida stellatoidea [176][143]. Morroniside, which was identified in S. alata [42][144], has been investigated extensively. It has therapeutic effects in multiple organs and their systems [177,178][145][146]. Morroniside shows therapeutic results in rats after acute myocardial infarction by promoting angiogenesis and improved heart function [179][147]. It also prevents apoptosis of cardiomyocytes induced by high glucose [180][148]. In the skeletal system, morroniside promotes osteoblast proliferation [181][149] and formation through PI3K/Akt/mTOR signaling both in vitro and in vivo [182][150]. Morroniside activates Akt and extracellular signal-regulated kinase (ERK) to promote cartilage cell survival and matrix synthesis [183][151]. It downregulates factors associated with inflammation and cartilage degradation in chondrocytes which suggests that it may be a potential protective bioactive compound against osteoarthritis [184][152].
In neurodegenerative disease, morroniside inhibits the phosphorylation of JNK, p38/MAPK and tau, and is thought to potentially aid in the treatment of Alzheimer’s disease [185,186][153][154]. Due to its antioxidant effect, morroniside improves the activity of endogenous glutathione in neuroblastoma cells. In vivo, morroniside reduces the infarct size of rats with focal cerebral ischemia and promotes the recovery of nerve functions [187][155].
Pretreatment with morroniside can reduce the production of ROS, inhibit the expression of apoptosis-related protein (Bax) and increase the expression of the antiapoptotic gene Bcl-2, to block mitochondrion-mediated apoptosis, and ultimately reduce the apoptosis of neuroblastoma cells induced by H2O2 [188][156]. Through its antioxidant activity, morroniside exerts neuroprotective effects in spinal cord injury and may be an effective treatment for this condition [189][157]. As it regulates hair follicle growth and development, partly through the Wnt/β-catenin signaling pathway, morroniside may be a potential treatment for hair loss [190][158].
Pulegone is a naturally occurring organic compound obtained from the essential oils of several plants from the Lamiaceae family such as Mentha piperita [191][159] that is widely used in flavoring agents, perfumery and aromatherapy [192][160]. In Sarracenia, it functions as an attractant but also as an insecticide [193][161] because it interferes with insect feeding behavior, development and reproduction [194][162]. This dual role suggests that in Sarracenia species it could also play a role in prey killing [13][163]. Pulegone shows significant antibacterial and fungicidal activity [195,196,197][164][165][166] as well as antihistaminic properties [198][167]. Pulegone exhibits anti-inflammatory activities through the regulation of NF-κB, MAPK and erythroid 2-related factor 2 (Nrf2)/heme oxygenase (HO)-1 signaling pathways. It also induces significant antioxidative effects by scavenging ROS generation in RAW 264.7 murine macrophage cells [199][168].
p-cymene is a volatile compound extracted from S. alata [45][169]. It shows anti-inflammatory activity, being able to modulate cytokine (TNF-α, IL-1β, IL-6) production in vitro and in vivo [200][170] and exhibits cytotoxic activity against a large variety of cancer cell lines such as breast, ovarian, melanoma, colorectal and hepatocellular [201][171].

3. Triterpenes

Triterpenes are a diverse group of natural compounds widely distributed in the plant kingdom and found in leaves, stem bark, fruits and roots. They are biogenetically derived from active isoprene and the frequent object of phytochemical and pharmacological investigations [202][172]. The triterpenes found in Sarraceniaceae species are betulinic acid, betulin, ursolic acid, lupeol, α-amyrin and β-sitosterol. Betulin (lup-20(29)-ene-3b,28-diol) is a lupane-type compound, characterized by an isopropylidene group and five-membered ring. Together with the derivative betulinic acid (3-beta-hydroxy-lup20(29)-en-28-oic acid), it is widely distributed throughout the plant kingdom [203][173]. In recent experiments, S. purpurea hairy roots induced with Agrobacterium rhizogenes have yielded polyphenols and triterpenes such as betulinic acid [204][174].

Biological Activity

Betulin and α-amyrin have recently been found in a S. purpurea root extract which exhibits cytotoxicity towards the in vitro survival, migration and proliferation of mammary carcinoma cells with high tumorigenic and invasive potential [205][175]. Betulin and betulinic acid inhibit proliferation and induce apoptosis in various cancer cell lines such as breast [206][176], prostate [207][177], colorectal [208][178], leukemia [209][179] and lung [210][180]. They also manifest cytotoxic activity against multidrug-resistant tumor cells [211][181]. The anticancer properties of betulinic acid are associated with its ability induce apoptosis in malignant cells through both the extrinsic and intrinsic pathways [212,213][182][183]. Betulinic acid significantly represses the migration and invasion of human renal carcinoma cells in vitro and in vivo [214][184]. It has the ability to suppress inflammation and to regulate the immune response by modulating NF-κB activity [215][185] and inhibiting the cyclooxygenase pathway [216][186]. It can also decrease oxidative and nitrosative stress through the reduction in iNOS expression and nitric oxide [217][187]. Inhibition of NF-κB is also a mechanism through which betulinic acid exerts protective effects against diabetic nephropathy [218][188].
Betulinic acid protects the brains of rats from neurodegeneration and neuronal damage by diminishing the hippocampal proinflammatory cytokines and reducing oxidative stress, which results in decreased histological damage to the hippocampus [219,220][189][190]. Both betulin and betulinic acid have been tested with promising results against HIV, HSV, human papilloma virus, influenza virus and multidrug resistant bacteria [215][185]. The antibacterial activity of betulin, betulinic acid and ursolic acid against E. coli, P. aeruginosa and S. aureus is due to increased ROS generation that leads to lipid peroxidation, DNA fragmentation and bacterial death [221][191]. Betulinic acid has a high safety margin, as the tested dose range needed to inhibit prostate cancer growth in vitro and in vivo does not cause systemic side effects in mice [222][192]. Betulinic acid is toxic to neoplastic cells but only weakly toxic towards normal cells [223][193]. Betulin, on the other hand, shows toxicity in normal fish and murine fibroblasts [224][194].
Lupeol decreases the generation of proinflammatory cytokines such as TNF-α and interleukin β (ILβ) in lipopolysaccharide-treated macrophages [225][195]. Lupeol suppresses inflammatory mediators, and provides protection against neuroinflammation in the brains of mice [226][196]. The antitumor effects of lupeol are associated with its potential to modulate signaling pathways such as NF-κB and the PI3K/Akt pathway which are reported to play an important role during tumorigenesis. Lupeol kills prostate cancer cells and spares normal prostate epithelial cells, with the targeted pathways being Wnt/β-catenin signaling and Fas receptor apoptotic machinery [227,228][197][198].
Ursolic acid (3-beta-3-hydroxy-urs-12-ene-28-oic-acid) is a lipophilic pentacyclic triterpenoid [229][199]. As it influences cell signaling pathways, inhibits enzyme activity, induces apoptosis and reduces tumor growth, ursolic acid is considered a promising compound for cancer prevention and therapy [230][200]. It displays significant antitumor effects by suppressing cell proliferation and inducing cell cycle arrest in gallbladder carcinoma cells, both in vitro and in vivo [231][201]. Ursolic acid has antihyperglycemic action mediated through insulin secretion and an insulinomimetic effect on glucose uptake. It also stimulates synthesis, and translocation of glucose transporter protein GLUT4 by a mechanism of crosstalk between calcium and protein kinases. These effects make ursolic acid a potential antidiabetic agent with pharmacological properties for insulin resistance and diabetes therapy [232][202]. This triterpene shows potent activity against several bacterial species such as S. aureus, Enterococcus faecalis, S. mutans, S. sobrinus and Mycobacterium tuberculosis [233,234,235][203][204][205]. Unfortunately, low solubility and stability of ursolic acid in aqueous medium hinder its therapeutic application and require the development of water-soluble formulations [230,236][200][206].
Ursolic acid, betulin, betulinic acid, lupeol and other pentacyclic triterpenes increase glucose absorption, insulin secretion and glucose uptake in peripheral organs, contributing to the management of diabetes and diabetes-induced complications such as vascular dysfunction, retinopathy and nephropathy [237][207].
α-amyrin does not exhibit a strong antiproliferative activity against ovarian, pancreatic and stomach cancer cell lines [238][208]. It stimulates proliferation of human keratinocytes but does not protect them against UVB damage [239][209]. Together with its isomer β-amyrin, α-amyrin has peripheral and central analgesic effects independent of the opioid system, and also shows a potent anti-inflammatory activity [240][210].
β-sitosterol, a bioactive phytosterol, is naturally present in plant cell membranes. Its chemical structure is similar to the mammalian cell-derived cholesterol [241][211]. β-sitosterol reduces oxygen free radicals and hydrogen peroxide levels in RAW 264.7 cells and stimulates enzymatic antioxidants. It also reverts the impairment in glutathione/oxidized glutathione ratio, leading to the conclusion that phytosterol can scavenge ROS [242][212]. Due to its potency as an antioxidant and hypolipidemic agent, treatment with β-sitosterol decreased the levels of stress and lipid parameters, resulting in normal levels of insulin receptor (IR) and GLUT4 in diabetic rats fed with a high-fat diet [243][213]. β-sitosterol has anti-inflammatory properties, being able to inhibit phosphorylation of NF-κB and the activity of this transcription factor in macrophage cells [244][214].

4. Sesquiterpenes

Among the sesquiterpenes found in S. alata, the predominant ones are β-caryophyllene and α-bergamotene [45][169]. β-caryophyllene is a volatile compound of essential oils from many herbs and spices [245][215] including Cannabis sativa [246][216].

Biological Activity

The ability of β-caryophyllene to bind to cannabinoid receptor type 2 (CB2) stimulates both MAPK and PI3K signaling pathways which results in anticancer and analgesic properties [247][217]. Due to this selectivity towards CB2, it has applications for various pathological conditions such as nervous system disorders and various inflammatory diseases (rheumatoid arthritis, atherosclerosis) [248][218]. α-bergamotene is one of the main components of essential oil extracted from Citrus medica fruit which has high antioxidant and antimicrobial activity against Gram-positive bacteria (Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus), Gram-negative bacteria (Escherichia coli) and yeast (Saccharomyces cerevisiae) [249][219].
 

References

  1. Tsao, R. Chemistry and Biochemistry of Dietary Polyphenols. Nutrients 2010, 2, 1231–1246. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An Overview. J. Nutr. Sci. 2016, 5, e47.
  2. Samanta, A.; Das, S.K. Roles of Flavonoids in Plants. Int. J. Pharm. Sci. Tech. 2011, 6, 12–35.
  3. Dos Santos Nascimento, L.B.; Tattini, M. Beyond Photoprotection: The Multifarious Roles of Flavonoids in Plant Terrestrialization. Int. J. Mol. Sci. 2022, 23, 5284.
  4. Tan, Z.; Halter, B.; Liu, D.; Gilbert, E.R.; Cline, M.A. Dietary Flavonoids as Modulators of Lipid Metabolism in Poultry. Front. Physiol. 2022, 13, 863860.
  5. Rodrigues, A.C.; de Oliveira, B.D.; da Silva, E.R.; Sacramento, N.T.B.; Bertoldi, M.C.; Pinto, U.M. Anti-Quorum Sensing Activity of Phenolic Extract from Eugenia Brasiliensis (Brazilian Cherry). Food Sci. Technol. 2016, 36, 337–343.
  6. Quecan, B.X.V.; Santos, J.T.C.; Rivera, M.L.C.; Hassimotto, N.M.A.; Almeida, F.A.; Pinto, U.M. Effect of Quercetin Rich Onion Extracts on Bacterial Quorum Sensing. Front. Microbiol. 2019, 10, 867.
  7. Tušek, M.; Curman, M.; Babić, M.; Tkalec, M. Photochemical Efficiency, Content of Photosynthetic Pigments and Phenolic Compounds in Different Pitcher Parts of Sarracenia Hybrids. Acta Bot. Croat. 2016, 75, 179–185.
  8. Newell, S.J.; Nastase, A.J. Efficiency of Insect Capture by Sarracenia Purpurea (Sarraceniaceae), the Northern Pitcher Plant. Am. J. Bot. 1998, 85, 88–91.
  9. Ockermann, P.; Headley, L.; Lizio, R.; Hansmann, J. A Review of the Properties of Anthocyanins and Their Influence on Factors Affecting Cardiometabolic and Cognitive Health. Nutrients 2021, 13, 2831.
  10. Salehi, B.; Sharifi-Rad, J.; Cappellini, F.; Reiner, Ž.; Zorzan, D.; Imran, M.; Sener, B.; Kilic, M.; El-Shazly, M.; Fahmy, N.M.; et al. The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action. Front. Pharmacol. 2020, 11, 1300.
  11. Naing, A.H.; Kim, C.K. Abiotic Stress-induced Anthocyanins in Plants: Their Role in Tolerance to Abiotic Stresses. Physiol. Plant. 2021, 172, 1711–1723.
  12. Rienth, M.; Vigneron, N.; Darriet, P.; Sweetman, C.; Burbidge, C.; Bonghi, C.; Walker, R.P.; Famiani, F.; Castellarin, S.D. Grape Berry Secondary Metabolites and Their Modulation by Abiotic Factors in a Climate Change Scenario–A Review. Front. Plant Sci. 2021, 12, 643258.
  13. Kong, J.-M.; Chia, L.-S.; Goh, N.-K.; Chia, T.-F.; Brouillard, R. Analysis and Biological Activities of Anthocyanins. Phytochemistry 2003, 64, 923–933.
  14. Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and Anthocyanins: Colored Pigments as Food, Pharmaceutical Ingredients, and the Potential Health Benefits. Food Nutr. Res. 2017, 61, 1361779.
  15. Oliveira, H.; Fernandes, A.; Brás, N.F.; Mateus, N.; de Freitas, V.; Fernandes, I. Anthocyanins as Antidiabetic Agents—In Vitro and In Silico Approaches of Preventive and Therapeutic Effects. Molecules 2020, 25, 3813.
  16. Tsuda, T. Dietary Anthocyanin-Rich Plants: Biochemical Basis and Recent Progress in Health Benefits Studies. Mol. Nutr. Food Res. 2012, 56, 159–170.
  17. Sheridan, P.M.; Griesbach, R.J. Anthocyanidins of Sarracenia L. Flowers and Leaves. HortScience 2001, 36, 384.
  18. Schnell, D.E.; Sarracenia, L. Petal Extract Chromatography. Castanea 1978, 43, 107–115.
  19. Bendokas, V.; Stanys, V.; Mažeikienė, I.; Trumbeckaite, S.; Baniene, R.; Liobikas, J. Anthocyanins: From the Field to the Antioxidants in the Body. Antioxidants 2020, 9, 819.
  20. Huang, C.-C.; Hung, C.-H.; Hung, T.-W.; Lin, Y.-C.; Wang, C.-J.; Kao, S.-H. Dietary Delphinidin Inhibits Human Colorectal Cancer Metastasis Associating with Upregulation of MiR-204-3p and Suppression of the Integrin/FAK Axis. Sci. Rep. 2019, 9, 18954.
  21. Tsuda, T.; Horio, F.; Uchida, K.; Aoki, H.; Osawa, T. Dietary Cyanidin 3-O-β-D-Glucoside-Rich Purple Corn Color Prevents Obesity and Ameliorates Hyperglycemia in Mice. J. Nutr. 2003, 133, 2125–2130.
  22. Afzal, M.; Redha, A.; AlHasan, R. Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease. Molecules 2019, 24, 4255.
  23. Husain, A.; Chanana, H.; Khan, S.A.; Dhanalekshmi, U.M.; Ali, M.; Alghamdi, A.A.; Ahmad, A. Chemistry and Pharmacological Actions of Delphinidin, a Dietary Purple Pigment in Anthocyanidin and Anthocyanin Forms. Front. Nutr. 2022, 9, 746881.
  24. Tarozzi, A.; Morroni, F.; Hrelia, S.; Angeloni, C.; Marchesi, A.; Cantelli-Forti, G.; Hrelia, P. Neuroprotective Effects of Anthocyanins and Their in Vivo Metabolites in SH-SY5Y Cells. Neurosci. Lett. 2007, 424, 36–40.
  25. Kim, S.M.; Chung, M.J.; Ha, T.J.; Choi, H.N.; Jang, S.J.; Kim, S.O.; Chun, M.H.; Do, S.I.; Choo, Y.K.; Park, Y. Il Neuroprotective Effects of Black Soybean Anthocyanins via Inactivation of ASK1–JNK/P38 Pathways and Mobilization of Cellular Sialic Acids. Life Sci. 2012, 90, 874–882.
  26. Diaconeasa, Z.; Știrbu, I.; Xiao, J.; Leopold, N.; Ayvaz, Z.; Danciu, C.; Ayvaz, H.; Stǎnilǎ, A.; Nistor, M.; Socaciu, C. Anthocyanins, Vibrant Color Pigments, and Their Role in Skin Cancer Prevention. Biomedicines 2020, 8, 336.
  27. Lim, W.-C.; Kim, H.; Kim, Y.-J.; Park, S.-H.; Song, J.-H.; Lee, K.H.; Lee, I.H.; Lee, Y.-K.; So, K.A.; Choi, K.-C.; et al. Delphinidin Inhibits BDNF-Induced Migration and Invasion in SKOV3 Ovarian Cancer Cells. Bioorg. Med. Chem. Lett. 2017, 27, 5337–5343.
  28. Maya-Cano, D.A.; Arango-Varela, S.; Santa-Gonzalez, G.A. Phenolic Compounds of Blueberries (Vaccinium Spp) as a Protective Strategy against Skin Cell Damage Induced by ROS: A Review of Antioxidant Potential and Antiproliferative Capacity. Heliyon 2021, 7, e06297.
  29. Chen, Y.; Ge, Z.; Huang, S.; Zhou, L.; Zhai, C.; Chen, Y.; Hu, Q.; Cao, W.; Weng, Y.; Li, Y. Delphinidin Attenuates Pathological Cardiac Hypertrophy via the AMPK/NOX/MAPK Signaling Pathway. Aging 2020, 12, 5362–5383.
  30. Les, F.; Cásedas, G.; Gómez, C.; Moliner, C.; Valero, M.S.; López, V. The Role of Anthocyanins as Antidiabetic Agents: From Molecular Mechanisms to in Vivo and Human Studies. J. Physiol. Biochem. 2021, 77, 109–131.
  31. Moriwaki, S.; Suzuki, K.; Muramatsu, M.; Nomura, A.; Inoue, F.; Into, T.; Yoshiko, Y.; Niida, S. Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice. PLoS ONE 2014, 9, e97177.
  32. Murata, M.; Kosaka, R.; Kurihara, K.; Yamashita, S.; Tachibana, H. Delphinidin Prevents Disuse Muscle Atrophy and Reduces Stress-Related Gene Expression. Biosci. Biotechnol. Biochem. 2016, 80, 1636–1640.
  33. Samarpita, S.; Rasool, M. Cyanidin Attenuates IL-17A Cytokine Signaling Mediated Monocyte Migration and Differentiation into Mature Osteoclasts in Rheumatoid Arthritis. Cytokine 2021, 142, 155502.
  34. Calland, N.; Sahuc, M.-E.; Belouzard, S.; Pène, V.; Bonnafous, P.; Mesalam, A.A.; Deloison, G.; Descamps, V.; Sahpaz, S.; Wychowski, C.; et al. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. J. Virol. 2015, 89, 10053–10063.
  35. Vázquez-Calvo, Á.; Jiménez de Oya, N.; Martín-Acebes, M.A.; Garcia-Moruno, E.; Saiz, J.-C. Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus. Front. Microbiol. 2017, 8, 1314.
  36. Gervasi, T.; Calderaro, A.; Barreca, D.; Tellone, E.; Trombetta, D.; Ficarra, S.; Smeriglio, A.; Mandalari, G.; Gattuso, G. Biotechnological Applications and Health-Promoting Properties of Flavonols: An Updated View. Int. J. Mol. Sci. 2022, 23, 1710.
  37. Roewer, N.; Broscheit, J. Use of Delphinidin against Staphylococcus Aureus. U.S. Patent Application No. 14/389,492, 2013.
  38. Hollman, P.C.; Arts, I.C. Flavonols, Flavones and Flavanols-Nature, Occurrence and Dietary Burden. J. Sci. Food Agric. 2000, 80, 1081–1093.
  39. Rashid, M.I.; Fareed, M.I.; Rashid, H.; Aziz, H.; Ehsan, N.; Khalid, S.; Ghaffar, I.; Ali, R.; Gul, A.; Hakeem, K.R. Flavonoids and Their Biological Secrets. In Plant and Human Health; Springer International Publishing: Cham, Switzerland, 2019; Volume 2, pp. 579–605.
  40. Romeo, J.T.; Bacon, J.D.; Mabry, T.J. Ecological Considerations of Amino Acids and Flavonoids in Sarracenia Species. Biochem. Syst. Ecol. 1977, 5, 117–120.
  41. Hotti, H.; Gopalacharyulu, P.; Seppänen-Laakso, T.; Rischer, H. Metabolite Profiling of the Carnivorous Pitcher Plants Darlingtonia and Sarracenia. PLoS ONE 2017, 12, e0171078.
  42. Miles, D.H.; Kokpol, U.; Mody, V.; Hedin, P.A. Volatiles in Sarracenia Flava. Phytochemistry 1975, 14, 845–846.
  43. Jürgens, A.; El-Sayed, A.M.; Suckling, D.M. Do Carnivorous Plants Use Volatiles for Attracting Prey Insects? Funct. Ecol. 2009, 23, 875–887.
  44. Miles, D.H.; Kokpol, U.; Zalkow, L.H.; Steindel, S.J.; Nabors, J.B. Tumor Inhibitors I: Preliminary Investigation of Antitumor Activity of Sarracenia Flava. J. Pharm. Sci. 1974, 63, 613–615.
  45. Miles, D.H.; Kokpol, U. Tumor Inhibitors II: Constituents and Antitumor Activity of Sarracenia Flava. J. Pharm. Sci. 1976, 65, 284–285.
  46. Hall, B.; Rapinski, M.; Spoor, D.; Eid, H.; Saleem, A.; Arnason, J.T.; Foster, B.; Cuerrier, A.; Haddad, P.S.; Harris, C.S. A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee. Front. Pharmacol. 2022, 12, 511078.
  47. Muhammad, A.; Guerrero-Analco, J.A.; Martineau, L.C.; Musallam, L.; Madiraju, P.; Nachar, A.; Saleem, A.; Haddad, P.S.; Arnason, J.T. Antidiabetic Compounds from Sarracenia Purpurea Used Traditionally by the Eeyou Istchee Cree First Nation. J. Nat. Prod. 2012, 75, 1284–1288.
  48. Muhammad, A.; Haddad, P.S.; Durst, T.; Arnason, J.T. Phytochemical Constituents of Sarracenia Purpurea L. (Pitcher Plant). Phytochemistry 2013, 94, 238–242.
  49. Cieniak, C.; Walshe-Roussel, B.; Liu, R.; Muhammad, A.; Saleem, A.; Haddad, P.S.; Cuerrier, A.; Foster, B.C.; Arnason, J.T. Phytochemical Comparison of the Water and Ethanol Leaf Extracts of the Cree Medicinal Plant, Sarracenia Purpurea L. (Sarraceniaceae). J. Pharm. Pharm. Sci. 2015, 18, 484.
  50. Eid, H.M.; Martineau, L.C.; Saleem, A.; Muhammad, A.; Vallerand, D.; Benhaddou-Andaloussi, A.; Nistor, L.; Afshar, A.; Arnason, J.T.; Haddad, P.S. Stimulation of AMP-Activated Protein Kinase and Enhancement of Basal Glucose Uptake in Muscle Cells by Quercetin and Quercetin Glycosides, Active Principles of the Antidiabetic Medicinal Plant Vaccinium Vitis-Idaea. Mol. Nutr. Food Res. 2010, 54, 991–1003.
  51. Shang, N.; Saleem, A.; Musallam, L.; Walshe-Roussel, B.; Badawi, A.; Cuerrier, A.; Arnason, J.T.; Haddad, P.S. Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee. PLoS ONE 2015, 10, e0135721.
  52. Eid, H.M.; Haddad, P.S. Mechanisms of Action of Indigenous Antidiabetic Plants from the Boreal Forest of Northeastern Canada. Adv. Endocrinol. 2014, 2014, 272968.
  53. Harris, C.S.; Asim, M.; Saleem, A.; Haddad, P.S.; Arnason, J.T.; Bennett, S. AL Characterizing the Cytoprotective Activity of Sarracenia Purpurea L., a Medicinal Plant That Inhibits Glucotoxicity in PC12 Cells. BMC Complement. Altern. Med. 2012, 12, 245.
  54. Li, S.; Pasquin, S.; Eid, H.M.; Gauchat, J.-F.; Saleem, A.; Haddad, P.S. Anti-Apoptotic Potential of Several Antidiabetic Medicinal Plants of the Eastern James Bay Cree Pharmacopeia in Cultured Kidney Cells. BMC Complement. Altern. Med. 2018, 18, 37.
  55. Thuan, N.H.; Shrestha, A.; Trung, N.T.; Tatipamula, V.B.; Van Cuong, D.; Canh, N.X.; Van Giang, N.; Kim, T.; Sohng, J.K.; Dhakal, D. Advances in Biochemistry and the Biotechnological Production of Taxifolin and Its Derivatives. Biotechnol. Appl. Biochem. 2022, 69, 848–861.
  56. Butterweck, V.; Jürgenliemk, G.; Nahrstedt, A.; Winterhoff, H. Flavonoids from Hypericum Perforatum Show Antidepressant Activity in the Forced Swimming Test. Planta Med. 2000, 66, 3–6.
  57. Das, A.; Baidya, R.; Chakraborty, T.; Samanta, A.K.; Roy, S. Pharmacological Basis and New Insights of Taxifolin: A Comprehensive Review. Biomed. Pharmacother. 2021, 142, 112004.
  58. Topal, F.; Nar, M.; Gocer, H.; Kalin, P.; Kocyigit, U.M.; Gülçin, İ.; Alwasel, S.H. Antioxidant Activity of Taxifolin: An Activity–Structure Relationship. J. Enzyme Inhib. Med. Chem. 2016, 31, 674–683.
  59. Kolhir, V.K.; Bykov, V.A.; Baginskaja, A.I.; Sokolov, S.Y.; Glazova, N.G.; Leskova, T.E.; Sakovich, G.S.; Tjukavkina, N.A.; Kolesnik, Y.A.; Rulenko, I.A. Antioxidant Activity of a Dihydroquercetin Isolated from Larix Gmelinii (Rupr.) Rupr. Wood. Phyther. Res. 1996, 10, 478–482.
  60. Dok-Go, H.; Lee, K.H.; Kim, H.J.; Lee, E.H.; Lee, J.; Song, Y.S.; Lee, Y.-H.; Jin, C.; Lee, Y.S.; Cho, J. Neuroprotective Effects of Antioxidative Flavonoids, Quercetin, (+)-Dihydroquercetin and Quercetin 3-Methyl Ether, Isolated from Opuntia Ficus-Indica Var. Saboten. Brain Res. 2003, 965, 130–136.
  61. Wang, Y.-H.; Wang, W.-Y.; Chang, C.-C.; Liou, K.-T.; Sung, Y.-J.; Liao, J.-F.; Chen, C.-F.; Chang, S.; Hou, Y.-C.; Chou, Y.-C.; et al. Taxifolin Ameliorates Cerebral Ischemia-Reperfusion Injury in Rats through Its Anti-Oxidative Effect and Modulation of NF-Kappa B Activation. J. Biomed. Sci. 2006, 13, 127–141.
  62. Zhang, H.-Q.; Wang, Y.-J.; Yang, G.-T.; Gao, Q.-L.; Tang, M.-X. Taxifolin Inhibits Receptor Activator of NF-ΚB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in Vitro and Prevents Lipopolysaccharide-Induced Bone Loss in Vivo. Pharmacology 2019, 103, 101–109.
  63. Pan, S.; Zhao, X.; Ji, N.; Shao, C.; Fu, B.; Zhang, Z.; Wang, R.; Qiu, Y.; Jin, M.; Kong, D. Inhibitory Effect of Taxifolin on Mast Cell Activation and Mast Cell-Mediated Allergic Inflammatory Response. Int. Immunopharmacol. 2019, 71, 205–214.
  64. Yang, C.-L.; Lin, Y.-S.; Liu, K.-F.; Peng, W.-H.; Hsu, C.-M. Hepatoprotective Mechanisms of Taxifolin on Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Nutrients 2019, 11, 2655.
  65. Itaya, S.; Igarashi, K. Effects of Taxifolin on the Serum Cholesterol Level in Rats. Biosci. Biotechnol. Biochem. 1992, 56, 1492–1494.
  66. Igarashi, K.; Uchida, Y.; Murakami, N.; Mizutani, K.; Masuda, H. Effect of Astilbin in Tea Processed from Leaves of Engelhardtia Chrysolepis on the Serum and Liver Lipid Concentrations and on the Erythrocyte and Liver Antioxidative Enzyme Activities of Rats. Biosci. Biotechnol. Biochem. 1996, 60, 513–515.
  67. Sunil, C.; Xu, B. An Insight into the Health-Promoting Effects of Taxifolin (Dihydroquercetin). Phytochemistry 2019, 166, 112066.
  68. Wasimul, H.; Shakti, P.P.; Barij, N.S. Evaluation of Taxifolin and Phloretin as Antiangiogenic Flavonoids: An in Vivo, in Vitro Experimental Analysis. Int. J. Pharm. Pharm. Sci. 2015, 7, 72–79.
  69. Kashyap, D.; Sharma, A.; Tuli, H.S.; Sak, K.; Punia, S.; Mukherjee, T.K. Kaempferol—A Dietary Anticancer Molecule with Multiple Mechanisms of Action: Recent Trends and Advancements. J. Funct. Foods 2017, 30, 203–219.
  70. Ren, J.; Lu, Y.; Qian, Y.; Chen, B.; Wu, T.; Ji, G. Recent Progress Regarding Kaempferol for the Treatment of Various Diseases. Exp. Ther. Med. 2019, 18, 2759–2776.
  71. Lee, J.-H.; Kim, G.-H. Evaluation of Antioxidant and Inhibitory Activities for Different Subclasses Flavonoids on Enzymes for Rheumatoid Arthritis. J. Food Sci. 2010, 75, H212–H217.
  72. Shukla, R.; Pandey, V.; Vadnere, G.P.; Lodhi, S. Role of Flavonoids in Management of Inflammatory Disorders. In Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases; Elsevier: Amsterdam, The Netherlands, 2019; pp. 293–322.
  73. Alam, W.; Khan, H.; Shah, M.A.; Cauli, O.; Saso, L. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing. Molecules 2020, 25, 4073.
  74. Kong, L.; Luo, C.; Li, X.; Zhou, Y.; He, H. The Anti-Inflammatory Effect of Kaempferol on Early Atherosclerosis in High Cholesterol Fed Rabbits. Lipids Health Dis. 2013, 12, 115.
  75. Navarro, S.L.; Schwarz, Y.; Song, X.; Wang, C.-Y.; Chen, C.; Trudo, S.P.; Kristal, A.R.; Kratz, M.; Eaton, D.L.; Lampe, J.W. Cruciferous Vegetables Have Variable Effects on Biomarkers of Systemic Inflammation in a Randomized Controlled Trial in Healthy Young Adults. J. Nutr. 2014, 144, 1850–1857.
  76. Hosseinpour-Niazi, S.; Mirmiran, P.; Fallah-Ghohroudi, A.; Azizi, F. Non-Soya Legume-Based Therapeutic Lifestyle Change Diet Reduces Inflammatory Status in Diabetic Patients: A Randomised Cross-over Clinical Trial. Br. J. Nutr. 2015, 114, 213–219.
  77. Geybels, M.S.; Verhage, B.A.J.; Arts, I.C.W.; van Schooten, F.J.; Goldbohm, R.A.; van den Brandt, P.A. Dietary Flavonoid Intake, Black Tea Consumption, and Risk of Overall and Advanced Stage Prostate Cancer. Am. J. Epidemiol. 2013, 177, 1388–1398.
  78. Vellosa, J.C.R.; Regasini, L.O.; Khalil, N.M.; Bolzani, V.d.S.; Khalil, O.A.K.; Manente, F.A.; Pasquini Netto, H.; Oliveira, O.M.M.d.F. Antioxidant and Cytotoxic Studies for Kaempferol, Quercetin and Isoquercitrin. Eclét. Quím. 2011, 36, 07–20.
  79. Sharma, V.; Joseph, C.; Ghosh, S.; Agarwal, A.; Mishra, M.K.; Sen, E. Kaempferol Induces Apoptosis in Glioblastoma Cells through Oxidative Stress. Mol. Cancer Ther. 2007, 6, 2544–2553.
  80. Wu, L.-Y.; Lu, H.-F.; Chou, Y.-C.; Shih, Y.-L.; Bau, D.-T.; Chen, J.-C.; Hsu, S.-C.; Chung, J.-G. Kaempferol Induces DNA Damage and Inhibits DNA Repair Associated Protein Expressions in Human Promyelocytic Leukemia HL-60 Cells. Am. J. Chin. Med. 2015, 43, 365–382.
  81. Zhu, L.; Xue, L. Kaempferol Suppresses Proliferation and Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Breast Cancer Cells. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 2019, 27, 629–634.
  82. Sharma, N.; Biswas, S.; Al-Dayan, N.; Alhegaili, A.S.; Sarwat, M. Antioxidant Role of Kaempferol in Prevention of Hepatocellular Carcinoma. Antioxidants 2021, 10, 1419.
  83. Yang, G.; Xing, J.; Aikemu, B.; Sun, J.; Zheng, M. Kaempferol Exhibits a Synergistic Effect with Doxorubicin to Inhibit Proliferation, Migration, and Invasion of Liver Cancer. Oncol. Rep. 2021, 45, 32.
  84. Ferrara, N. Vascular Endothelial Growth Factor as a Target for Anticancer Therapy. Oncologist 2004, 9, 2–10.
  85. Luo, H.; Rankin, G.O.; Juliano, N.; Jiang, B.-H.; Chen, Y.C. Kaempferol Inhibits VEGF Expression and in Vitro Angiogenesis through a Novel ERK-NFκB-CMyc-P21 Pathway. Food Chem. 2012, 130, 321–328.
  86. Ramos, S. Effects of Dietary Flavonoids on Apoptotic Pathways Related to Cancer Chemoprevention. J. Nutr. Biochem. 2007, 18, 427–442.
  87. do Nascimento, J.E.T.; Rodrigues, A.L.M.; de Lisboa, D.S.; Liberato, H.R.; Falcão, M.J.C.; da Silva, C.R.; Nobre Júnior, H.V.; Braz Filho, R.; de Paula Junior, V.F.; Alves, D.R.; et al. Chemical Composition and Antifungal In Vitro and In Silico, Antioxidant, and Anticholinesterase Activities of Extracts and Constituents of Ouratea Fieldingiana (DC.) Baill. Evid. Based Complement. Altern. Med. 2018, 2018, 1748487.
  88. Yarmolinsky, L.; Huleihel, M.; Zaccai, M.; Ben-Shabat, S. Potent Antiviral Flavone Glycosides from Ficus Benjamina Leaves. Fitoterapia 2012, 83, 362–367.
  89. Ku, S.-K.; Kwak, S.; Kwon, O.-J.; Bae, J.-S. Hyperoside Inhibits High-Glucose-Induced Vascular Inflammation In Vitro and In Vivo. Inflammation 2014, 37, 1389–1400.
  90. Jin, X.; Yan, E.; Wang, H.; Sui, H.; Liu, Z.; Gao, W.; Jin, Y. Hyperoside Exerts Anti-Inflammatory and Anti-Arthritic Effects in LPS-Stimulated Human Fibroblast-like Synoviocytes in Vitro and in Mice with Collagen-Induced Arthritis. Acta Pharmacol. Sin. 2016, 37, 674–686.
  91. Wang, L.; Yue, Z.; Guo, M.; Fang, L.; Bai, L.; Li, X.; Tao, Y.; Wang, S.; Liu, Q.; Zhi, D.; et al. Dietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF- κ B Signaling. Biomed Res. Int. 2016, 2016, 1068528.
  92. Zhang, R.; Wei, Y.; Yang, T.; Huang, X.; Zhou, J.; Yang, C.; Zhou, J.; Liu, Y.; Shi, S. Inhibitory Effects of Quercetin and Its Major Metabolite Quercetin-3-O-β-D-glucoside on Human UDP-glucuronosyltransferase 1A Isoforms by Liquid Chromatography-tandem Mass Spectrometry. Exp. Ther. Med. 2021, 22, 842.
  93. Lesjak, M.; Beara, I.; Simin, N.; Pintać, D.; Majkić, T.; Bekvalac, K.; Orčić, D.; Mimica-Dukić, N. Antioxidant and Anti-Inflammatory Activities of Quercetin and Its Derivatives. J. Funct. Foods 2018, 40, 68–75.
  94. Krasteva, I.; Nikolova, I.; Danchev, N.; Nikolov, S. Phytochemical Analysis of Ethyl Acetate Extract from Astragalus Corniculatus Bieb. and Brain Antihypoxic Activity. Acta Pharm. 2004, 54, 151–156.
  95. Lee, S.; Lee, J.; Lee, H.; Sung, J. Relative Protective Activities of Quercetin, Quercetin-3-glucoside, and Rutin in Alcohol-induced Liver Injury. J. Food Biochem. 2019, 43, e13002.
  96. Lee, J.; Lee, J.; Kim, S.J.; Kim, J.H. Quercetin-3-O-Glucoside Suppresses Pancreatic Cancer Cell Migration Induced by Tumor-Deteriorated Growth Factors In Vitro. Oncol. Rep. 2016, 35, 2473–2479.
  97. Nile, A.; Nile, S.H.; Shin, J.; Park, G.; Oh, J.-W. Quercetin-3-Glucoside Extracted from Apple Pomace Induces Cell Cycle Arrest and Apoptosis by Increasing Intracellular ROS Levels. Int. J. Mol. Sci. 2021, 22, 10749.
  98. You, H.J.; Ahn, H.J.; Ji, G.E. Transformation of Rutin to Antiproliferative Quercetin-3-Glucoside by Aspergillus Niger. J. Agric. Food Chem. 2010, 58, 10886–10892.
  99. dos Santos, A.E.; Kuster, R.M.; Yamamoto, K.A.; Salles, T.S.; Campos, R.; de Meneses, M.D.; Soares, M.R.; Ferreira, D. Quercetin and Quercetin 3-O-Glycosides from Bauhinia Longifolia (Bong.) Steud. Show Anti-Mayaro Virus Activity. Parasit. Vectors 2014, 7, 130.
  100. Fan, D.; Zhou, X.; Zhao, C.; Chen, H.; Zhao, Y.; Gong, X. Anti-Inflammatory, Antiviral and Quantitative Study of Quercetin-3-O-β-D-Glucuronide in Polygonum perfoliatum L. Fitoterapia 2011, 82, 805–810.
  101. Qiu, X.; Kroeker, A.; He, S.; Kozak, R.; Audet, J.; Mbikay, M.; Chrétien, M. Prophylactic Efficacy of Quercetin 3-β- O-d -Glucoside against Ebola Virus Infection. Antimicrob. Agents Chemother. 2016, 60, 5182–5188.
  102. Wong, G.; He, S.; Siragam, V.; Bi, Y.; Mbikay, M.; Chretien, M.; Qiu, X. Antiviral Activity of Quercetin-3-β-O-D-Glucoside against Zika Virus Infection. Virol. Sin. 2017, 32, 545–547.
  103. Sholkamy, E.N.; Muthukrishnan, P.; Abdel-Raouf, N.; Nandhini, X.; Ibraheem, I.B.M.; Mostafa, A.A. Antimicrobial and Antinematicidal Metabolites from Streptomyces Cuspidosporus Strain SA4 against Selected Pathogenic Bacteria, Fungi and Nematode. Saudi J. Biol. Sci. 2020, 27, 3208–3220.
  104. Ganeshpurkar, A.; Saluja, A.K. The Pharmacological Potential of Rutin. Saudi Pharm. J. 2017, 25, 149–164.
  105. Tyszczuk, K. Sensitive Voltammetric Determination of Rutin at an in Situ Plated Lead Film Electrode. J. Pharm. Biomed. Anal. 2009, 49, 558–561.
  106. Meng, X.-L.; Yu, M.-M.; Liu, Y.-C.; Gao, Y.-L.; Chen, X.-S.; Shou, S.-T.; Chai, Y.-F. Rutin Inhibits Cardiac Apoptosis and Prevents Sepsis-Induced Cardiomyopathy. Front. Physiol. 2022, 13, 834077.
  107. Kreft, I.; Fabjan, N.; Yasumoto, K. Rutin Content in Buckwheat (Fagopyrum Esculentum Moench) Food Materials and Products. Food Chem. 2006, 98, 508–512.
  108. Patel, K.; Patel, D.K. The Beneficial Role of Rutin, A Naturally Occurring Flavonoid in Health Promotion and Disease Prevention: A Systematic Review and Update. In Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases; Watson, R.R., Preedy, V., Eds.; Elsevier: London, UK, 2019; pp. 457–479.
  109. Enogieru, A.B.; Haylett, W.; Hiss, D.C.; Bardien, S.; Ekpo, O.E. Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. Oxid. Med. Cell. Longev. 2018, 2018, 6241017.
  110. Peres, D.A.; de Oliveira, C.A.; da Costa, M.S.; Tokunaga, V.K.; Mota, J.P.; Rosado, C.; Consiglieri, V.O.; Kaneko, T.M.; Velasco, M.V.R.; Baby, A.R. Rutin Increases Critical Wavelength of Systems Containing a Single UV Filter and with Good Skin Compatibility. Ski. Res. Technol. 2016, 22, 325–333.
  111. Choi, S.J.; Lee, S.-N.; Kim, K.; Joo, D.H.; Shin, S.; Lee, J.; Lee, H.K.; Kim, J.; Kwon, S.B.; Kim, M.J.; et al. Biological Effects of Rutin on Skin Aging. Int. J. Mol. Med. 2016, 38, 357–363.
  112. Pinzaru, I.; Chioibas, R.; Marcovici, I.; Coricovac, D.; Susan, R.; Predut, D.; Georgescu, D.; Dehelean, C. Rutin Exerts Cytotoxic and Senescence-Inducing Properties in Human Melanoma Cells. Toxics 2021, 9, 226.
  113. Karakurt, S. Modulatory Effects of Rutin on the Expression of Cytochrome P450s and Antioxidant Enzymes in Human Hepatoma Cells. Acta Pharm. 2016, 66, 491–502.
  114. Kowalczyk, T.; Sitarek, P.; Skała, E.; Toma, M.; Wielanek, M.; Pytel, D.; Wieczfińska, J.; Szemraj, J.; Śliwiński, T. Induction of Apoptosis by in Vitro and in Vivo Plant Extracts Derived from Menyanthes Trifoliata L. in Human Cancer Cells. Cytotechnology 2019, 71, 165–180.
  115. Turan, I.; Demir, S.; Kilinc, K.; Burnaz, N.A.; Yaman, S.O.; Akbulut, K.; Mentese, A.; Aliyazicioglu, Y.; Deger, O. Antiproliferative and Apoptotic Effect of Morus Nigra Extract on Human Prostate Cancer Cells. Saudi Pharm. J. 2017, 25, 241–248.
  116. Li, X.; Liu, Z.; Gu, Y.; Lv, Z.; Chen, Y.; Gao, H. Expression of NF-KappaB and P38 under Intervention of Rutin in Lung Cancer Therapy. Biomed. Res. 2017, 28, 2344–2347.
  117. Corsale, I.; Carrieri, P.; Martellucci, J.; Piccolomini, A.; Verre, L.; Rigutini, M.; Panicucci, S. Flavonoid Mixture (Diosmin, Troxerutin, Rutin, Hesperidin, Quercetin) in the Treatment of I–III Degree Hemorroidal Disease: A Double-Blind Multicenter Prospective Comparative Study. Int. J. Colorectal Dis. 2018, 33, 1595–1600.
  118. Nasri Nasrabadi, P.; Zareian, S.; Nayeri, Z.; Salmanipour, R.; Parsafar, S.; Gharib, E.; Asadzadeh Aghdaei, H.; Zali, M.R. A Detailed Image of Rutin Underlying Intracellular Signaling Pathways in Human SW480 Colorectal Cancer Cells Based on MiRNAs-lncRNAs-mRNAs-TFs Interactions. J. Cell. Physiol. 2019, 234, 15570–15580.
  119. Ding, H.; Li, Y.; Zhao, C.; Yang, Y.; Xiong, C.; Zhang, D.; Feng, S.; Wu, J.; Wang, X. Rutin Supplementation Reduces Oxidative Stress, Inflammation and Apoptosis of Mammary Gland in Sheep During the Transition Period. Front. Vet. Sci. 2022, 9, 907299.
  120. Sachetto, A.T.A.; Rosa, J.G.; Santoro, M.L. Rutin (Quercetin-3-Rutinoside) Modulates the Hemostatic Disturbances and Redox Imbalance Induced by Bothrops Jararaca Snake Venom in Mice. PLoS Negl. Trop. Dis. 2018, 12, e0006774.
  121. Sachetto, A.T.A.; Miyamoto, J.G.; Tashima, A.K.; de Souza, A.O.; Santoro, M.L. The Bioflavonoids Rutin and Rutin Succinate Neutralize the Toxins of B. Jararaca Venom and Inhibit Its Lethality. Front. Pharmacol. 2022, 13, 828269.
  122. Di Pierro, F.; Derosa, G.; Maffioli, P.; Bertuccioli, A.; Togni, S.; Riva, A.; Allegrini, P.; Khan, A.; Khan, S.; Khan, B.A.; et al. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int. J. Gen. Med. 2021, 14, 2359–2366.
  123. Di Pierro, F.; Iqtadar, S.; Khan, A.; Ullah Mumtaz, S.; Masud Chaudhry, M.; Bertuccioli, A.; Derosa, G.; Maffioli, P.; Togni, S.; Riva, A.; et al. Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int. J. Gen. Med. 2021, 14, 2807–2816.
  124. Kumari, A.; Rajput, V.S.; Nagpal, P.; Kukrety, H.; Grover, S.; Grover, A. Dual Inhibition of SARS-CoV-2 Spike and Main Protease through a Repurposed Drug, Rutin. J. Biomol. Struct. Dyn. 2022, 40, 4987–4999.
  125. Youn, H.S.; Lee, J.Y.; Saitoh, S.I.; Miyake, K.; Kang, K.W.; Choi, Y.J.; Hwang, D.H. Suppression of MyD88- and TRIF-Dependent Signaling Pathways of Toll-like Receptor by (−)-Epigallocatechin-3-Gallate, a Polyphenol Component of Green Tea. Biochem. Pharmacol. 2006, 72, 850–859.
  126. Liu, S.-H.; Lu, T.-H.; Su, C.-C.; Lay, I.-S.; Lin, H.-Y.; Fang, K.-M.; Ho, T.-J.; Chen, K.-L.; Su, Y.-C.; Chiang, W.-C.; et al. Lotus Leaf (Nelumbo Nucifera) and Its Active Constituents Prevent Inflammatory Responses in Macrophages via JNK/NF-ΚB Signaling Pathway. Am. J. Chin. Med. 2014, 42, 869–889.
  127. Fan, F.-Y.; Sang, L.-X.; Jiang, M. Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease. Molecules 2017, 22, 484.
  128. Pan, Z.; Zhou, Y.; Luo, X.; Ruan, Y.; Zhou, L.; Wang, Q.; Yan, Y.J.; Liu, Q.; Chen, J. Against NF-ΚB/Thymic Stromal Lymphopoietin Signaling Pathway, Catechin Alleviates the Inflammation in Allergic Rhinitis. Int. Immunopharmacol. 2018, 61, 241–248.
  129. Ohishi, T.; Goto, S.; Monira, P.; Isemura, M.; Nakamura, Y. Anti-Inflammatory Action of Green Tea. Antiinflamm. Antiallergy Agents Med. Chem. 2016, 15, 74–90.
  130. Kopustinskiene, D.M.; Savickas, A.; Vetchý, D.; Masteikova, R.; Kasauskas, A.; Bernatoniene, J. Direct Effects of (−)-Epicatechin and Procyanidin B2 on the Respiration of Rat Heart Mitochondria. Biomed Res. Int. 2015, 2015, 232836.
  131. Xie, H.; Li, X.; Ren, Z.; Qiu, W.; Chen, J.; Jiang, Q.; Chen, B.; Chen, D. Antioxidant and Cytoprotective Effects of Tibetan Tea and Its Phenolic Components. Molecules 2018, 23, 179.
  132. Zanwar, A.A.; Badole, S.L.; Shende, P.S.; Hegde, M.V.; Bodhankar, S.L. Antioxidant Role of Catechin in Health and Disease. In Polyphenols in Human Health and Disease; Elsevier: Amsterdam, The Netherlands, 2014; pp. 267–271.
  133. Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. Potent Anti-Amyloidogenic and Fibril-Destabilizing Effects of Polyphenols in Vitro: Implications for the Prevention and Therapeutics of Alzheimer’s Disease. J. Neurochem. 2003, 87, 172–181.
  134. Omar, S.H. Biophenols. In Discovery and Development of Neuroprotective Agents from Natural Products; Elsevier: Amsterdam, The Netherlands, 2018; pp. 103–148.
  135. Han, S.; Kollmer, M.; Markx, D.; Claus, S.; Walther, P.; Fändrich, M. Amyloid Plaque Structure and Cell Surface Interactions of β-Amyloid Fibrils Revealed by Electron Tomography. Sci. Rep. 2017, 7, 43577.
  136. Ide, K.; Matsuoka, N.; Yamada, H.; Furushima, D.; Kawakami, K. Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives. Molecules 2018, 23, 2357.
  137. Pervin, M.; Unno, K.; Ohishi, T.; Tanabe, H.; Miyoshi, N.; Nakamura, Y. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules 2018, 23, 1297.
  138. Wang, C.; Gong, X.; Bo, A.; Zhang, L.; Zhang, M.; Zang, E.; Zhang, C.; Li, M. Iridoids: Research Advances in Their Phytochemistry, Biological Activities, and Pharmacokinetics. Molecules 2020, 25, 287.
  139. Miles, D.H.; Kokpol, U.; Bhattacharyya, J.; Atwood, J.L.; Stone, K.E.; Bryson, T.A.; Wilson, C. Structure of Sarracenin. An Unusual Enol Diacetal Monoterpene from the Insectivorous Plant Sarracenia Flava. J. Am. Chem. Soc. 1976, 98, 1569–1573.
  140. Jaffé, K.; Blum, M.S.; Fales, H.M.; Mason, R.T.; Cabrera, A. On Insect Attractants from Pitcher Plants of the GenusHeliamphora (Sarraceniaceae). J. Chem. Ecol. 1995, 21, 379–384.
  141. Newman, T.; Ibrahim, S.; Wheeler, J.W.; McLaughlin, W.; Petersen, R.L.; Duffield, R.M. Identification of Sarracenin in Four Species of Sarracenia (Sarraceniaceae). Biochem. Syst. Ecol. 2000, 28, 193–195.
  142. Tor-Anyiin, T.A.; Igoli, J.O.; Anyam, J.V.; Anyam, J.N. Isolation and Antimicrobial Activity of Sarracenin from Root Bark of Strychnos Spinosa. J. Chem. Soc. Niger. 2015, 40, 71–75.
  143. Hu, J.-F.; Starks, C.M.; Williams, R.B.; Rice, S.M.; Norman, V.L.; Olson, K.M.; Hough, G.W.; Goering, M.G.; O’Neil-Johnson, M.; Eldridge, G.R. Secoiridoid Glycosides from the Pitcher Plant Sarracenia Alata. Helv. Chim. Acta 2009, 92, 273–280.
  144. Dong, Y.; Feng, Z.-L.; Chen, H.-B.; Wang, F.-S.; Lu, J.-H. Corni Fructus: A Review of Chemical Constituents and Pharmacological Activities. Chin. Med. 2018, 13, 34.
  145. Dinda, B. Pharmacology and Applications of Naturally Occurring Iridoids, 1st ed.; Springer Nature: Cham, Switzerland, 2019.
  146. Liu, T.; Sun, F.; Cui, J.; Zheng, S.; Li, Z.; Guo, D.; Tian, X.; Zhu, Z.; Zheng, W.; Wang, Y.; et al. Morroniside Enhances Angiogenesis and Improves Cardiac Function Following Acute Myocardial Infarction in Rats. Eur. J. Pharmacol. 2020, 872, 172954.
  147. Pi, W.-X.; Feng, X.-P.; Ye, L.-H.; Cai, B.-C. Combination of Morroniside and Diosgenin Prevents High Glucose-Induced Cardiomyocytes Apoptosis. Molecules 2017, 22, 163.
  148. Hu, N.; Ren, S.; Li, W.; Zhang, T.; Zhao, C. Morroniside Promotes Bone Marrow Mesenchymal Stem Cell Proliferation in Rats. Mol. Med. Rep. 2013, 7, 1565–1570.
  149. Liu, H.; Li, X.; Lin, J.; Lin, M. Morroniside Promotes the Osteogenesis by Activating PI3K/Akt/MTOR Signaling. Biosci. Biotechnol. Biochem. 2021, 85, 332–339.
  150. Cheng, L.; Zeng, G.; Liu, Z.; Zhang, B.; Cui, X.; Zhao, H.; Zheng, X.; Song, G.; Kang, J.; Xia, C. Protein Kinase B and Extracellular Signal-regulated Kinase Contribute to the Chondroprotective Effect of Morroniside on Osteoarthritis Chondrocytes. J. Cell. Mol. Med. 2015, 19, 1877–1886.
  151. Park, E.; Lee, C.G.; Han, S.J.; Yun, S.H.; Hwang, S.; Jeon, H.; Kim, J.; Choi, C.W.; Yang, S.; Jeong, S.-Y. Antiosteoarthritic Effect of Morroniside in Chondrocyte Inflammation and Destabilization of Medial Meniscus-Induced Mouse Model. Int. J. Mol. Sci. 2021, 22, 2987.
  152. Yang, C.; Kuai, X.; Gao, W.; Yu, J.; Wang, Q.; Li, L.; Zhang, L. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration. J. Alzheimer’s Dis. 2016, 51, 33–44.
  153. Chen, K.; Lu, Y.; Liu, C.; Zhang, L.; Fang, Z.; Yu, G. Morroniside Prevents H2O2 or Aβ1–42-Induced Apoptosis via Attenuating JNK and P38 MAPK Phosphorylation. Eur. J. Pharmacol. 2018, 834, 295–304.
  154. Wang, W.; Sun, F.; An, Y.; Ai, H.; Zhang, L.; Huang, W.; Li, L. Morroniside Protects Human Neuroblastoma SH-SY5Y Cells against Hydrogen Peroxide-Induced Cytotoxicity. Eur. J. Pharmacol. 2009, 613, 19–23.
  155. Zhang, J.-X.; Wang, R.; Xi, J.; Shen, L.; Zhu, A.-Y.; Qi, Q.; Wang, Q.-Y.; Zhang, L.-J.; Wang, F.-C.; Lü, H.-Z.; et al. Morroniside Protects SK-N-SH Human Neuroblastoma Cells against H2O2-Induced Damage. Int. J. Mol. Med. 2017, 39, 603–612.
  156. Duan, F.-X.; Shi, Y.-J.; Chen, J.; Song, X.; Shen, L.; Qi, Q.; Ding, S.-Q.; Wang, Q.-Y.; Wang, R.; Lü, H.-Z.; et al. The Neuroprotective Role of Morroniside against Spinal Cord Injury in Female Rats. Neurochem. Int. 2021, 148, 105105.
  157. Zhou, L.; Wang, H.; Jing, J.; Yu, L.; Wu, X.; Lu, Z. Morroniside Regulates Hair Growth and Cycle Transition via Activation of the Wnt/β-Catenin Signaling Pathway. Sci. Rep. 2018, 8, 13785.
  158. Liu, C.; Gao, Q.; Shang, Z.; Liu, J.; Zhou, S.; Dang, J.; Liu, L.; Lange, I.; Srividya, N.; Lange, B.M.; et al. Functional Characterization and Structural Insights Into Stereoselectivity of Pulegone Reductase in Menthol Biosynthesis. Front. Plant Sci. 2021, 12, 780970.
  159. Božović, M.; Ragno, R. Calamintha Nepeta (L.) Savi and Its Main Essential Oil Constituent Pulegone: Biological Activities and Chemistry. Molecules 2017, 22, 290.
  160. Franzios, G.; Mirotsou, M.; Hatziapostolou, E.; Kral, J.; Scouras, Z.G.; Mavragani-Tsipidou, P. Insecticidal and Genotoxic Activities of Mint Essential Oils. J. Agric. Food Chem. 1997, 45, 2690–2694.
  161. Gunderson, C.A.; Samuelian, J.H.; Evans, C.K.; Brattsten, L.B. Effects of the Mint Monoterpene Pulegone on Spodoptera Eridania (Lepidoptera: Noctuidae). Environ. Entomol. 1985, 14, 859–861.
  162. Hatcher, C.R.; Ryves, D.B.; Millett, J. The Function of Secondary Metabolites in Plant Carnivory. Ann. Bot. 2020, 125, 399–411.
  163. Scortichini, M.; Rossi, M.P. Preliminary in Vitro Evaluation of the Antimicrobial Activity of Terpenes and Terpenoids towards Erwinia Amylovora (Burrill) Winslow et Al. J. Appl. Bacteriol. 1991, 71, 109–112.
  164. Dhingra, A.K.; Chopra, B.; Bhardwaj, S.; Dhar, K.L. Synthesis and Characterization of Novel Pulegone Derivatives as Substitutes of 4-(1,1 Dimethylethyl) Cyclohexan-1-Ol Acetate. J. Pharm. Res. 2011, 4, 19–21.
  165. González-Chávez, M.M.; Cárdenas-Ortega, N.C.; Méndez-Ramos, C.A.; Pérez-Gutiérrez, S. Fungicidal Properties of the Essential Oil of Hesperozygis Marifolia on Aspergillus Flavus Link. Molecules 2011, 16, 2501–2506.
  166. de Urbina, A.V.O.; Martin, M.L.; Montero, M.J.; Carron, R.; Sevilla, M.A.; San Roman, L. Antihistaminic Activity of Pulegone on the Guinea-Pig Ileum. J. Pharm. Pharmacol. 2011, 42, 295–296.
  167. Roy, A.; Park, H.-J.; Abdul, Q.A.; Jung, H.A.; Choi, J.S. Pulegone Exhibits Anti-Inflammatory Activities through the Regulation of NF-ΚB and Nrf-2 Signaling Pathways in LPS-Stimulated RAW 264.7 Cells. Nat. Prod. Sci. 2018, 24, 28.
  168. Łyczko, J.; Twardowski, J.P.; Skalny, B.; Galek, R.; Szumny, A.; Gruss, I.; Piesik, D.; Sendel, S. Sarracenia Alata (Alph. Wood) Alph.Wood Microcuttings as a Source of Volatiles Potentially Responsible for Insects’ Respond. Molecules 2021, 26, 2406.
  169. Marchese, A.; Arciola, C.; Barbieri, R.; Silva, A.; Nabavi, S.; Tsetegho Sokeng, A.; Izadi, M.; Jafari, N.; Suntar, I.; Daglia, M.; et al. Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene. Materials 2017, 10, 947.
  170. Balahbib, A.; El Omari, N.; Hachlafi, N.E.; Lakhdar, F.; El Menyiy, N.; Salhi, N.; Mrabti, H.N.; Bakrim, S.; Zengin, G.; Bouyahya, A. Health Beneficial and Pharmacological Properties of P-Cymene. Food Chem. Toxicol. 2021, 153, 112259.
  171. Nazaruk, J.; Borzym-Kluczyk, M. The Role of Triterpenes in the Management of Diabetes Mellitus and Its Complications. Phytochem. Rev. 2015, 14, 675–690.
  172. Hordyjewska, A.; Ostapiuk, A.; Horecka, A.; Kurzepa, J. Betulin and Betulinic Acid: Triterpenoids Derivatives with a Powerful Biological Potential. Phytochem. Rev. 2019, 18, 929–951.
  173. Pilarska, K.M.; Panić, M.; Redovniković, I.R.; Wróbel-Kwiatkowska, M. Characterization of Carnivorous Plants Sarracenia Purpurea L. Transformed with Agrobacterium Rhizogenes. Mapp. Intimacies 2021.
  174. Huang, Y.-H.; Chiang, W.-Y.; Chen, P.-J.; Lin, E.-S.; Huang, C.-Y. Anticancer and Antioxidant Activities of the Root Extract of the Carnivorous Pitcher Plant Sarracenia Purpurea. Plants 2022, 11, 1668.
  175. Liby, K.; Honda, T.; Williams, C.R.; Risingsong, R.; Royce, D.B.; Suh, N.; Dinkova-Kostova, A.T.; Stephenson, K.K.; Talalay, P.; Sundararajan, C.M.; et al. Novel Semisynthetic Analogues of Betulinic Acid with Diverse Cytoprotective, Antiproliferative, and Proapoptotic Activities. Mol. Cancer Ther. 2007, 6, 2113–2119.
  176. Shankar, E.; Zhang, A.; Franco, D.; Gupta, S. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves P53 and Nuclear Factor-Kappa B (NF-ΚB) Pathways. Molecules 2017, 22, 264.
  177. Bębenek, E.; Chrobak, E.; Piechowska, A.; Głuszek, S.B. Betulin: A Natural Product with Promising Anticancer Activity against Colorectal Cancer Cells. Med. Stud. Med. 2020, 36, 298–302.
  178. Dash, S.K.; Chattopadhyay, S.; Dash, S.S.; Tripathy, S.; Das, B.; Mahapatra, S.K.; Bag, B.G.; Karmakar, P.; Roy, S. Self Assembled Nano Fibers of Betulinic Acid: A Selective Inducer for ROS/TNF-Alpha Pathway Mediated Leukemic Cell Death. Bioorg. Chem. 2015, 63, 85–100.
  179. Zhan, X.; Li, J.; Zhang, S.; Xing, P.; Xia, M. Betulinic Acid Exerts Potent Antitumor Effects on Paclitaxel-resistant Human Lung Carcinoma Cells (H460) via G2/M Phase Cell Cycle Arrest and Induction of Mitochondrial Apoptosis. Oncol. Lett. 2018, 16, 3628–3634.
  180. Saeed, M.E.M.; Mahmoud, N.; Sugimoto, Y.; Efferth, T.; Abdel-Aziz, H. Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR). Front. Pharmacol. 2018, 9, 481.
  181. Xu, T.; Pang, Q.; Wang, Y.; Yan, X. Betulinic Acid Induces Apoptosis by Regulating PI3K/Akt Signaling and Mitochondrial Pathways in Human Cervical Cancer Cells. Int. J. Mol. Med. 2017, 40, 1669–1678.
  182. Xu, Y.; Li, J.; Li, Q.-J.; Feng, Y.-L.; Pan, F. Betulinic Acid Promotes TRAIL Function on Liver Cancer Progression Inhibition through P53/Caspase-3 Signaling Activation. Biomed. Pharmacother. 2017, 88, 349–358.
  183. Yang, C.; Li, Y.; Fu, L.; Jiang, T.; Meng, F. Betulinic Acid Induces Apoptosis and Inhibits Metastasis of Human Renal Carcinoma Cells in Vitro and in Vivo. J. Cell. Biochem. 2018, 119, 8611–8622.
  184. Amiri, S.; Dastghaib, S.; Ahmadi, M.; Mehrbod, P.; Khadem, F.; Behrouj, H.; Aghanoori, M.-R.; Machaj, F.; Ghamsari, M.; Rosik, J.; et al. Betulin and Its Derivatives as Novel Compounds with Different Pharmacological Effects. Biotechnol. Adv. 2020, 38, 107409.
  185. Viji, V.; Helen, A.; Luxmi, V.R. Betulinic Acid Inhibits Endotoxin-Stimulated Phosphorylation Cascade and pro-Inflammatory Prostaglandin E2 Production in Human Peripheral Blood Mononuclear Cells. Br. J. Pharmacol. 2011, 162, 1291–1303.
  186. Nader, M.A.; Baraka, H.N. Effect of Betulinic Acid on Neutrophil Recruitment and Inflammatory Mediator Expression in Lipopolysaccharide-Induced Lung Inflammation in Rats. Eur. J. Pharm. Sci. 2012, 46, 106–113.
  187. Wang, S.; Yang, Z.; Xiong, F.; Chen, C.; Chao, X.; Huang, J.; Huang, H. Betulinic Acid Ameliorates Experimental Diabetic-Induced Renal Inflammation and Fibrosis via Inhibiting the Activation of NF-ΚB Signaling Pathway. Mol. Cell. Endocrinol. 2016, 434, 135–143.
  188. Kaundal, M.; Deshmukh, R.; Akhtar, M. Protective Effect of Betulinic Acid against Intracerebroventricular Streptozotocin Induced Cognitive Impairment and Neuronal Damage in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism. Pharmacol. Rep. 2018, 70, 540–548.
  189. Navabi, S.P.; Sarkaki, A.; Mansouri, E.; Badavi, M.; Ghadiri, A.; Farbood, Y. The Effects of Betulinic Acid on Neurobehavioral Activity, Electrophysiology and Histological Changes in an Animal Model of the Alzheimer’s Disease. Behav. Brain Res. 2018, 337, 99–106.
  190. Oloyede, H.O.B.; Ajiboye, H.O.; Salawu, M.O.; Ajiboye, T.O. Influence of Oxidative Stress on the Antibacterial Activity of Betulin, Betulinic Acid and Ursolic Acid. Microb. Pathog. 2017, 111, 338–344.
  191. Chintharlapalli, S.; Papineni, S.; Ramaiah, S.K.; Safe, S. Betulinic Acid Inhibits Prostate Cancer Growth through Inhibition of Specificity Protein Transcription Factors. Cancer Res. 2007, 67, 2816–2823.
  192. Zuco, V.; Supino, R.; Righetti, S.C.; Cleris, L.; Marchesi, E.; Gambacorti-Passerini, C.; Formelli, F. Selective Cytotoxicity of Betulinic Acid on Tumor Cell Lines, but Not on Normal Cells. Cancer Lett. 2002, 175, 17–25.
  193. Małaczewska, J.; Kaczorek-Łukowska, E.; Kazuń, B. High Cytotoxicity of Betulin towards Fish and Murine Fibroblasts: Is Betulin Safe for Nonneoplastic Cells? BMC Vet. Res. 2021, 17, 198.
  194. Fernández, M.A.; de las Heras, B.; Garcia, M.D.; Sáenz, M.T.; Villar, A. New Insights into the Mechanism of Action of the Anti-Inflammatory Triterpene Lupeol. J. Pharm. Pharmacol. 2010, 53, 1533–1539.
  195. Ahmad, R.; Khan, A.; Lee, H.J.; Ur Rehman, I.; Khan, I.; Alam, S.I.; Kim, M.O. Lupeol, a Plant-Derived Triterpenoid, Protects Mice Brains against Aβ-Induced Oxidative Stress and Neurodegeneration. Biomedicines 2020, 8, 380.
  196. Saleem, M.; Kweon, M.H.; Yun, J.M.; Adhami, V.M.; Khan, N.; Syed, D.N.; Mukhtar, H. A Novel Dietary Triterpene Lupeol Induces Fas-Mediated Apoptotic Death of Androgen-Sensitive Prostate Cancer Cells and Inhibits Tumor Growth in a Xenograft Model. Cancer Res. 2005, 65, 11203–11213.
  197. Saleem, M.; Murtaza, I.; Tarapore, R.S.; Suh, Y.; Adhami, V.M.; Johnson, J.J.; Siddiqui, I.A.; Khan, N.; Asim, M.; Hafeez, B.B.; et al. Lupeol Inhibits Proliferation of Human Prostate Cancer Cells by Targeting -Catenin Signaling. Carcinogenesis 2009, 30, 808–817.
  198. Lee, S.Y.; Kim, Y.J.; Chung, S.O.; Park, S.U. Recent Studies on Ursolic Acid and Its Biological and Pharmacological Activity. EXCLI J. 2016, 15, 221–228.
  199. Schito, A.M.; Caviglia, D.; Piatti, G.; Zorzoli, A.; Marimpietri, D.; Zuccari, G.; Schito, G.C.; Alfei, S. Efficacy of Ursolic Acid-Enriched Water-Soluble and Not Cytotoxic Nanoparticles against Enterococci. Pharmaceutics 2021, 13, 1976.
  200. Weng, H.; Tan, Z.-J.; Hu, Y.-P.; Shu, Y.-J.; Bao, R.-F.; Jiang, L.; Wu, X.-S.; Li, M.-L.; Ding, Q.; Wang, X.; et al. Ursolic Acid Induces Cell Cycle Arrest and Apoptosis of Gallbladder Carcinoma Cells. Cancer Cell Int. 2014, 14, 96.
  201. Castro, A.J.G.; Frederico, M.J.S.; Cazarolli, L.H.; Mendes, C.P.; Bretanha, L.C.; Schmidt, É.C.; Bouzon, Z.L.; de Medeiros Pinto, V.A.; da Fonte Ramos, C.; Pizzolatti, M.G.; et al. The Mechanism of Action of Ursolic Acid as Insulin Secretagogue and Insulinomimetic Is Mediated by Cross-Talk between Calcium and Kinases to Regulate Glucose Balance. Biochim. Biophys. Acta-Gen. Subj. 2015, 1850, 51–61.
  202. Kim, S.-G.; Kim, M.-J.; Jin, D.-C.; Park, S.-N.; Cho, E.-G.; Freire, M.O.; Jang, S.-J.; Park, Y.-J.; Kook, J.-K. Antimicrobial Effect of Ursolic Acid and Oleanolic Acid against Methicillin-Resistant Staphylococcus Aureus. Korean J. Microbiol. 2012, 48, 212–215.
  203. Jesus, J.A.; Lago, J.H.G.; Laurenti, M.D.; Yamamoto, E.S.; Passero, L.F.D. Antimicrobial Activity of Oleanolic and Ursolic Acids: An Update. Evid. Based Complement. Altern. Med. 2015, 2015, 1–14.
  204. Jiménez-Arellanes, A.; Luna-Herrera, J.; Cornejo-Garrido, J.; López-García, S.; Castro-Mussot, M.E.; Meckes-Fischer, M.; Mata-Espinosa, D.; Marquina, B.; Torres, J.; Hernández-Pando, R. Ursolic and Oleanolic Acids as Antimicrobial and Immunomodulatory Compounds for Tuberculosis Treatment. BMC Complement. Altern. Med. 2013, 13, 258.
  205. Shakhtshneider, T.P.; Kuznetsova, S.A.; Zamay, A.S.; Zamay, T.N.; Spivak, E.A.; Mikhailenko, M.A.; Malyar, Y.N.; Kuznetsov, B.N.; Chesnokov, N.V.; Boldyrev, V.V. New Composites of Betulin Esters with Arabinogalactan as Highly Potent Anti-Cancer Agents. Nat. Prod. Res. 2016, 30, 1382–1387.
  206. Alqahtani, A.; Hamid, K.; Kam, A.; Wong, K.H.; Abdelhak, Z.; Razmovski-Naumovski, V.; Chan, K.; Li, K.M.; Groundwater, P.W.; Li, G.Q. The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications. Curr. Med. Chem. 2013, 20, 908–931.
  207. Dinku, W.; Isaksson, J.; Rylandsholm, F.G.; Bouř, P.; Brichtová, E.; Choi, S.U.; Lee, S.-H.; Jung, Y.-S.; No, Z.S.; Svendsen, J.S.M.; et al. Anti-Proliferative Activity of a Novel Tricyclic Triterpenoid Acid from Commiphora Africana Resin against Four Human Cancer Cell Lines. Appl. Biol. Chem. 2020, 63, 16.
  208. Biskup, E.; Gołębiowski, M.; Gniadecki, R.; Stepnowski, P.; Łojkowska, E. Triterpenoid A-amyrin Stimulates Proliferation of Human Keratinocytes but Does Not Protect Them against UVB Damage. Acta Biochim. Pol. 2012, 59, 255–260.
  209. Nogueira, A.O.; Oliveira, Y.I.S.; Adjafre, B.L.; de Moraes, M.E.A.; Aragão, G.F. Pharmacological Effects of the Isomeric Mixture of Alpha and Beta Amyrin from Protium Heptaphyllum: A Literature Review. Fundam. Clin. Pharmacol. 2019, 33, 4–12.
  210. Babu, S.; Jayaraman, S. An Update on β-Sitosterol: A Potential Herbal Nutraceutical for Diabetic Management. Biomed. Pharmacother. 2020, 131, 110702.
  211. Vivancos, M.; Moreno, J.J. β-Sitosterol Modulates Antioxidant Enzyme Response in RAW 264.7 Macrophages. Free Radic. Biol. Med. 2005, 39, 91–97.
  212. Ponnulakshmi, R.; Shyamaladevi, B.; Vijayalakshmi, P.; Selvaraj, J. In Silico and in Vivo Analysis to Identify the Antidiabetic Activity of Beta Sitosterol in Adipose Tissue of High Fat Diet and Sucrose Induced Type-2 Diabetic Experimental Rats. Toxicol. Mech. Methods 2019, 29, 276–290.
  213. Loizou, S.; Lekakis, I.; Chrousos, G.P.; Moutsatsou, P. β-Sitosterol Exhibits Anti-Inflammatory Activity in Human Aortic Endothelial Cells. Mol. Nutr. Food Res. 2010, 54, 551–558.
  214. Takemoto, Y.; Kishi, C.; Sugiura, Y.; Yoshioka, Y.; Matsumura, S.; Moriyama, T.; Zaima, N. Distribution of Inhaled Volatile β-Caryophyllene and Dynamic Changes of Liver Metabolites in Mice. Sci. Rep. 2021, 11, 1728.
  215. Hendriks, H.; Malingré, T.M.; Batterman, S.; Bos, R. Mono- and Sesqui-Terpene Hydrocarbons of the Essential Oil of Cannabis Sativa. Phytochemistry 1975, 14, 814–815.
  216. Fidyt, K.; Fiedorowicz, A.; Strządała, L.; Szumny, A. β -Caryophyllene and β -Caryophyllene Oxide-Natural Compounds of Anticancer and Analgesic Properties. Cancer Med. 2016, 5, 3007–3017.
  217. Francomano, F.; Caruso, A.; Barbarossa, A.; Fazio, A.; La Torre, C.; Ceramella, J.; Mallamaci, R.; Saturnino, C.; Iacopetta, D.; Sinicropi, M.S. β-Caryophyllene: A Sesquiterpene with Countless Biological Properties. Appl. Sci. 2019, 9, 5420.
  218. Xing, C.; Qin, C.; Li, X.; Zhang, F.; Linhardt, R.J.; Sun, P.; Zhang, A. Chemical Composition and Biological Activities of Essential Oil Isolated by HS-SPME and UAHD from Fruits of Bergamot. LWT 2019, 104, 38–44.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Academic Video Service
Feedback